サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Global Nucleic Acid Therapeutics Market (with Focus on Oligonucleotide): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

世界の核酸医薬市場(オリゴヌクレオチドに焦点を当てた):洞察と予測、COVOD-19の潜在的影響(2020−2024)

レポート概要

世界の核酸医薬市場は2024年に72億3,000万ドルに達すると予想され、2020−2024年のCAGRは33.3%と予想されます。がんの新規症例数の増加、遺伝子治療の普及拡大、医薬品研究開発費の増加、糖尿病罹患率の上昇、医療費の急増、診断に関する核酸技術の急速な進歩がこの市場の成長を後押しするでしょう。一方で、核酸医薬のデリバリー、RNAi医薬の開発に関する障壁、法的規制といった課題に直面するでしょう。

注目すべき課題としては、加速している感染症の拡大、医薬品やバイオテクノロジーのM&Aの進行、国の医療費支出の増加、核酸医薬の開発が挙げられます。この化合物群は近年、広範な疾患に対する非常に有望な医薬品候補を生み出すために出現したことから、世界の核酸医薬市場は高い収益性が見込まれる分野です。

核酸医薬は用途別に、単一遺伝子障害や多発性遺伝子障害の治療に使用されます。様々な単一遺伝子障害の高い罹患率が、様々な核酸医薬の用途拡大につながっており、これが今後この市場の成長を後押しするでしょう。

レポート詳細

目次

1. Overview
1.1 Introduction
1.2 Difference Between DNA and RNA
1.3 Nucleoside, Nucleotide & Nucleic Acid
1.4 Oligonucleotides
1.5 Comparison of ASO and siRNA Mechanisms
1.6 Nucleic Acid as Therapeutics
1.7 Categories of Nucleic Acid Therapeutics
1.8 Nucleic Acid Therapeutics in Gene Therapy

2. Impact of COVID-19
2.1 Rise in COVID-19 Testing
2.2 Growth in COVID-19 R&D Funding
2.3 Nucleic Acid Vaccines for COVID-19
2.4 Oligonucleotides and COVID-19 Pandemic

3. Global Nucleic Acid Therapeutics Market Analysis
3.1 Global Nucleic Acid Therapeutics Market by Value
3.2 Global Nucleic Acid Therapeutics Market Forecast by Value
3.3 Global Nucleic Acid Therapeutics Market Value by Application
3.3.1 Global Mono Genetic Nucleic Acid Therapeutics Market by Value
3.3.2 Global Mono Genetic Nucleic Acid Therapeutics Market Forecast by Value
3.3.3 Global Multi Genetic Nucleic Acid Therapeutics Market by Value
3.3.4 Global Multi Genetic Nucleic Acid Therapeutics Market Forecast by Value

4. Global Oligonucleotide Therapeutics Market Analysis
4.1 Global Oligonucleotide Therapeutics Market by Value
4.2 Global Oligonucleotide Therapeutics Market Forecast by Value
4.3 Global Oligonucleotide Therapeutics Market Value by Drugs Class
4.3.1 Global ASO (Antisense Oligonucleotide) Therapeutics Market by Value
4.3.2 Global ASO (Antisense Oligonucleotide) Therapeutics Market Forecast by Value
4.3.3 Global SiRNA (Small interfering RNA) Therapeutics Market Forecast by Value
4.4 Global Oligonucleotide Therapeutics Market Value by Regions

5. Regional Oligonucleotide Therapeutics Market Analysis
5.1 Americas
5.1.1 Americas Oligonucleotide Therapeutics Market Forecast by Value
5.2 Europe
5.2.1 Europe Oligonucleotide Therapeutics Market Forecast by Value
5.3 Asia Pacific
5.3.1 Asia Pacific Oligonucleotide Therapeutics Market Forecast by Value
5.4 Middle East & Africa
5.4.1 Middle East & Africa Oligonucleotide Therapeutics Market Forecast by Value

6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Incidences of New Cancer Cases
6.1.2 Rising Penetration of Gene Therapy
6.1.3 Increasing Pharmaceutical R&D Spending
6.1.4 Rise in Prevalence of Diabetes
6.1.5 Upsurge in Healthcare Expenditures
6.1.6 Rapid Advances in Nucleic Acid Technologies for Diagnostics
6.2 Key Trends and Developments
6.2.1 Accelerating Growth Rates of Infectious Diseases
6.2.2 Progress in Pharmaceutical and Biotech Merger & Acquisition
6.2.3 Growth in Government Spending on Healthcare
6.2.4 Development of Nucleic Acid Therapeutics
6.3 Challenges
6.3.1 Challenge of Delivering Nucleic Acid Therapeutics
6.3.2 Development Hurdles for RNAi Therapeutics
6.3.3 Legal Regulations
7.Competitive Landscape
7.1 Global Market
7.1.1 Key Players - Revenue Comparison
7.1.2 Key Players - R&D Expenditure Comparison
7.1.3 Key Players - Market Capitalization Comparison
7.1.4 Key Players - Nucleic Acid Drug Development and Patent Portfolio

8. Company Profiles
8.1 Alnylam Pharmaceuticals
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategies
8.2 Arrowhead Pharmaceuticals
8.2.1 Business Overview
8.2.3 Financial Overview
8.3.3 Business Strategies
8.3 Benitec Biopharma
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategies
8.4 WAVE Life Sciences
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategies
8.5 Vir Biotechnology
8.5.1 Business Overview
8.5.2 Financial Overview
8.5.3 Business Strategies
8.6 Protagonist Therapeutics
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Business Strategies

List of Figures
Nucleoside, Nucleotide & Nucleic Acid
COVID-19 Tests by Most Impacted Countries (2020)
Global Nucleic Acid Therapeutics Market by Value (2015-2019)
Global Nucleic Acid Therapeutics Market Forecast by Value (2020-2024)
Global Nucleic Acid Therapeutics Market Value by Application (2019)
Global Mono Genetic Nucleic Acid Therapeutics Market by Value (2015-2019)
Global Mono Genetic Nucleic Acid Therapeutics Market Forecast by Value (2020-2024)
Global Multi Genetic Nucleic Acid Therapeutics Market by Value (2015-2019)
Global Multi Genetic Nucleic Acid Therapeutics Market Forecast by Value (2020-2024)
Global Oligonucleotide Therapeutics Market by Value (2015-2019)
Global Oligonucleotide Therapeutics Market Forecast by Value (2020-2024)
Global Oligonucleotide Therapeutics Market Value by Drugs Class (2019)
Global ASO (Antisense Oligonucleotide) Therapeutics Market by Value (2015-2019)
Global ASO (Antisense Oligonucleotide) Therapeutics Market Forecast by Value (2020-2024)
Global SiRNA (Small interfering RNA) Therapeutics Market Forecast by Value (2017-2024)
Global Oligonucleotide Therapeutics Market Value by Regions (2019)
Americas Oligonucleotide Therapeutics Market Forecast by Value (2019-2024)
Europe Oligonucleotide Therapeutics Market Forecast by Value (2019-2024)
Asia Pacific Oligonucleotide Therapeutics Market Forecast by Value (2019-2024)
Middle East & Africa Oligonucleotide Therapeutics Market Forecast by Value (2019-2024)
Global New Cases of Top Cancer Types (2019)
Global Gene Therapy Market (2015-2019)
Global Pharmaceutical R&D Spending (2015-2019)
Global Diabetic Population (2010-2024)
Global Healthcare Expenditure Per Capita (2015-2019)
Global Growth Rate of Infectious Diseases Forecast (2017-2022)
Global Pharmaceutical and Biotech M&A (2015-2019)
Global Government Share on Health Spending (2019-2024)
FDA-Approved Nucleic Acid Therapeutics (2016-2019)
Alnylam Pharmaceuticals Revenue and Net Loss (2015-2019)
Alnylam Pharmaceuticals Revenue by Division (2019)
Arrowhead Pharmaceuticals Revenue and Net Income (Loss) (2015-2019)
Benitec Biopharma Revenue and Profit (Loss) (2015-2019)
Benitec Biopharma Revenue by Divisions (2019)
WAVE Life Sciences Revenues and Net Loss (2015-2019)
Vir Biotechnology Total Revenue and Net Loss (2017-2019)
Vir Biotechnology Total Revenue by Operations (2019)
Protagonist Therapeutics Revenue and Net Loss (2015-2019)

List of Tables
Difference Between DNA and RNA
Comparison of ASO and siRNA Mechanisms
Categories of Nucleic Acid Therapeutics
COVID-19 R&D Funding by Major Countries (2020)
mRNA Vaccine in Development for COVID-19
Key Players - Revenue Comparison (2019)
Key Players - R&D Expenditure Comparison (2019)
Key Players - Market Capitalization Comparison (2020)
Key Players - Nucleic Acid Drug Development and Patent Portfolio

発刊日

2020/10/08

体裁

PDF / 91ページ

販売価格

1,600USD

発行

Koncept Analytics

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品原料・製剤 / 疾病別治療・領域別治療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE